A drug manufacturer will pay more than $46 million and implement significant compliance program improvements to settle allegations that it offered kickbacks to doctors who prescribed its kidney drug.
Pharmaceuticals
Posted inPharmaceuticals
Former biopharm director heads to prison for insider trading ahead of Novartis purchase
A former director of biopharmaceutical company, Chinook Therapeutics, has been sentenced to prison for insider trading related to the company’s $3.2 billion sale to Novartis in 2023, a fraud detected through data analysis by the SEC.
Posted inPharmaceuticals
Orion Corporation announces GC
Pharmaceutical firm Orion Corporation announced that Mikko Kemppainen has been appointed as general counsel and secretary to the board of directors of Orion Corporation, and a member of the executive management board of the Orion Group, effective June 1.
Posted inPharmaceuticals
Terns Pharmaceuticals appoints legal chief
Terns Pharmaceuticals announced the appointment of Elona Kogan as chief legal officer.
Posted inPharmaceuticals
PharmaEssentia appoints legal head
PharmaEssentia USA announced the appointment of Beth Krewson as head of legal.
Posted inPharmaceuticals
Eli Lilly announces chief ethics and compliance officer retirement
Pharmaceuticals giant Eli Lilly and Company announced Alonzo Weems, executive vice president of enterprise risk management and chief ethics and compliance officer, will retire after 27 years of service with the company.
